Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Semaglutide Administration on Tobacco Use Behavior and Related Mechanisms Among Smokers With Obesity

NCT06986993 is registered in ClinicalTrials.gov with University of Oklahoma as lead sponsor.

NCT NCT06986993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06986993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Semaglutide Administration on Tobacco Use Behavior and Related Mechanisms Among Smokers With Obesity
Lead sponsor
University of Oklahoma
Phase
Phase 4
Overall status
Recruiting
Start date
July 1, 2024
Completion date
June 30, 2028
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tobacco use